DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Cardiovascular an Echocardiographic Assessment in Hypertension During Pregnancy

Information source: HaEmek Medical Center, Israel
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Pregnancy

Phase: Phase 3

Status: Recruiting

Sponsored by: HaEmek Medical Center, Israel

Official(s) and/or principal investigator(s):
Limor I Bushari, Principal Investigator, Affiliation: Heart Institute, Ha'Emek Medical Center

Overall contact:
Limor I Bushari, MD, Phone: 9724502000741, Email: limor_il@clalit.org.il

Summary

Cardiovascular & echocardiographic assessment in pregnant women with hypertension during their pregnancy in comparison to Pregnant normotensive women.

Clinical Details

Official title: Hypertension During Pregnancy: Cardiovascular & Echocardiographic Assessment: CREATION - P (01)

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: Hypertension impact on cardiovascular echocardiographic parameters and obstetric parameters in pregnant women with or without treatment

Secondary outcome: Primary outcome, Impact of alfa methyl dopa and labetolol on cardiovascular parameters in pregnant women

Detailed description: Cardiovascular & echocardiographic assessment in pregnant women with hypertension during their pregnancy in comparison to Pregnant normotensive women. Also,comparing echocardiographic parameters in hypertensive pregnant women being treated with either alfa methyl dopa or labetolol.

Eligibility

Minimum age: 18 Years. Maximum age: 60 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- hypertension during pregnancy: Chronic or pregnancy induced

Exclusion Criteria:

- Inability to sign informed consent

Locations and Contacts

Limor I Bushari, MD, Phone: 9724502000741, Email: limor_il@clalit.org.il

Ha'Emek Medical Center, Afula 18101, Israel; Recruiting
Limor I Bushari, MD, Phone: 972502000741, Email: limor_il@clalit.org.il
Nachum Zohar, Phone: 972547696562, Email: nachun_zo@clalit.org.il
Limor I Bushari, MD, Principal Investigator
Raed Salim, MD, Sub-Investigator
Nachum Zohar, MD, Sub-Investigator
Additional Information

Starting date: June 2009
Last updated: February 11, 2010

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017